Correlation or causation: Untangling the relationship between patent foramen ovale and migraine

Current Cardiology Reports

Volumn 9, Issue 1, 2007, Pages 7-12

  Adler, Eric ^a   Love, Barry ^a   Giovannone, Steve ^a   Volpicelli, Frank ^a   Goldman, Martin E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AIRWAY OBSTRUCTION; ANESTHESIA COMPLICATION; AORTA PERFORATION; BLOOD TRANSFUSION; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CORRELATION ANALYSIS; DACRON IMPLANT; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HEART TAMPONADE; HUMAN; INCIDENCE; LUNG EMBOLISM; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PERICARDIAL EFFUSION; PHYSICAL EXAMINATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL APPROACH; SURGICAL MORTALITY; THROMBOPHILIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WOUND INFECTION;

CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIGRAINE DISORDERS; PULMONARY CIRCULATION;

EID: 34047253909     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-007-0003-z     Document Type: Review

References (60)

1. Penther P: [Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies]. Arch Mal Coeur Vaiss 1994, 87:15-21.
2. Langholz D, Louie EK, Konstadt SN, et al.: Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol 1991, 18:1112-1117.
3. Meissner I, Whisnant JP, Khandheria BK, et al.: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999, 74:862-869.
4. Augoustides JG, Weiss SJ, Weiner J, et al.: Diagnosis of patent foramen ovale with multiplane transesophageal echocardiography in adult cardiac surgical patients. J Cardiothorac Vasc Anesth 2004, 18:725-730.
5. Yahia AM, Shaukat A, Kirmani JF, Qureshi AI: Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events. Echocardiography 2004, 21:517-522.
6. Beelke M, Angeli S, Del Sette M, et al.: Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003, 4:219-223.
7. Serafini O, Misuraca G, Greco F, et al.: [Prevalence of structural abnormalities of the atrial septum and their association with recent ischemic stroke or transient ischemic attack: echocardiographic evaluation in 18631 patients]. Ital Heart J Suppl 2003, 4:39-45.
8. Natanzon A, Goldman ME: Patent foramen ovale: anatomy versus pathophysiology - which determines stroke risk? J Am Soc Echocardiogr 2003, 16:71-76.
9. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
10. Homma S, Sacco RL: Patent foramen ovale and stroke. Circulation 2005, 112:1063-1072.
11. Woods TD: Transesophageal echocardiography and stroke. Curr Atheroscler Rep 2005, 7:255-262.
12. Cerrato P, Imperiale D, Priano L, et al.: Transoesophageal echocardiography in patients without arterial and major cardiac sources of embolism: difference between stroke subtypes. Cerebrovasc Dis 2002, 13:174-183.
13. Heckmann JG, Niedermeier W, Brandt-Pohlmann M, et al.: [Detection of patent foramen ovale. Transesophageal echocardiography and transcranial Doppler sonography with ultrasound contrast media are "supplementary, not competing, diagnostic methods"]. Med Klin (Munich) 1999, 94:367-370.
14. Brochet E, Habib G: [Intracardiac echocardiography during percutaneous closure of atrial septal defect and patent foramen ovalel. Arch Mal Coeur Vaiss 2005, 98:25-28.
15. Bartel T, Konorza T, Neudorf U, et al.: Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications. Eur J Echocardiogr 2005, 6:92-96.
16. Sliwka U, Job FP, Wissuwa D, et al.: Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism. A prospective study. Stroke 1995, 26:2067-2070.
17. Droste DW, Schmidt-Rimpler C, Wichter T, et al.: Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis 2004, 17:191-196.
18. Schulte-Altedorneburg G, Nam EM, Ritter M, et al.: On the origin of microembolic signals - a clinical and postmortem study. J Neurol 2003, 250:1044-1049.
19. Droste DW, Lakemeier S, Wichter T, et al.: Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke 2002, 33:2211-2216.
20. Droste DW, Jekentaite R, Stypmann J, et al.: Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of Echovist-200 and Echovist-300, timing of the Valsalva maneuver, and general recommendations for the performance of the test. Cerebrovasc Dis 2002, 13:235-241.
21. Sloan MA, Alexandrov AV, Tegeler CH, et al.: Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004, 62:1468-1481.
22. Mohrs OK, Petersen SE, Erkapic D, et al.: Diagnosis of patent foramen ovale using contrast-enhanced dynamic MRI: a pilot study. AJR Am J Roentgenol 2005, 184:234-240.
23. Buecker A, Spuentrup E, Grabitz R, et al.: Magnetic resonance-guided placement of atrial septal closure device in animal model of patent foramen ovale. Circulation 2002, 106:511-515.
24. Wahl A, Meier B, Haxel B, et al.: Prognosis after percutancous closure of patent foramen ovale for paradoxical embolism. Neurology 2001, 57:1330-1332.
25. Wahl A, Windecker S, Eberli FR, et al.: Percutaneous closure of patent foramen ovale in symptomatic patients. J Interv Cardiol 2001, 14:203-209.
26. Hijazi Z, Wang Z, Cao Q, et al.: Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Catheter Cardiovasc Interv 2001, 52:194-199.
27. Waight DJ, Cao QL, Hijazi ZM: Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices. Catheter Cardiovasc Interv 2000, 50:195-198.
28. Windecker S, Wahl A, Chatterjee T, et al.: Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000, 101:893-898.
29. Schwerzmann M, Windecker S, Wahl A, et al.: Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004, 90:186-190.
30. Wahl A, Krumsdorf U, Meier B, et al.: Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005, 45:377-380.
31. La Rosee K, Krause D, Becker M, et al.: [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients]. Dtsch Med Wochenschr 2001, 126:1030-1036.
32. Nedeltchev K, Arnold M, Wahl A, et al.: Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 2002, 72:347-350.
33. Bruch L, Parsi A, Grad MO, et al.: Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002, 105:2845-2848.
34. Bbrgermanna JHK, Friedricha I, Diez C: Recurrent thromboembolic events after percutaneous device closure of patent foramen ovale. Interac Cardiovasc Thorac Surg 2003, 2:125-127.
35. Lipton RB, Bigal ME: The epidemiology of migraine. Am J Med 2005, 118(Suppl)1:3S-10S.
36. Bigal ME, Lipton RB, Stewart WF: The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 2004, 4:98-104.
37. Steiner TJ, Scher AI, Stewart WF, et al.: The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003, 23:519-527.
38. Lipton RB, Liberman JN, Kolodner KB, et al.: Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 2003, 23:441-450.
39. Diener HC, Weimar C, Katsarava Z: Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005, 18:299-304.
40. Finsterer J, Sommer O, Stiskal M, et al.: Closure of a patent foramen ovale: effective therapy of migraine and occipital stroke. Int J Neurosci 2005, 115:119-127.
41. Lamy C, Giannesini C, Zuber M, et al.: Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial septal aneurysm. Stroke 2002, 33:706-711.
42. Anzola GP, Magoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52:1622-1625.
43. Ferrarini G, Malferrari G, Zucco R, et al.: High prevalence of patent foramen ovale in migraine with aura. J Headache Pain 2005, 6:71-76.
44. Dalla Volta G, Guindani M, Zavarise P, et al.: Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005, 6:328-330.
45. Tietjen GE: The risk of stroke in patients with migraine and implications for migraine management. CNS Drugs 2005, 19:683-692.
46. Gupta VK: Patent foramen ovale/atrial septal defect closure and migraine: searching the rationale for the procedure. J Am Coll Cardiol 2005, 46:737-738.
47. Steele JG, Nath PV, Burn J, et al.: An association between migrainous aura and hereditary hemorrhagic telangiectasia. Headache 1993, 33:145-148.
48. Garnier P, Michael D, Antoine JC, et al.: Myxoma of the left atrium with neurological manifestations: 8 cases. Rev Neurol 1994, 150:776-784.
49. Spence JD, Wong DG, Melendez LJ, et al.: Increased prevalence of mitral valve prolapse in patients with migraine. Can J Neurol Sci 1984, 131:1457-1460.
50. Giardini A, Donti A, Formigari R, et al.: Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006, 151:922.e1-922.e5.
51. Rahimtoola H, Egberts AC, Buurma H, et al.: Reduction in the intensity of abortive migraine drug use during coumarin therapy. Headache 2001, 41:768-773.
52. Schwerzmann M, Nedeltchev K, Lagger F, et al.: Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005, 65:1415-1418.
53. Wilmshurst P: Migraine Intervention With STARFlex Technology (MIST) trial. Presented at the annual European Association of Percutaneous Cardiovascular Interventions meeting. Paris: May 24-27, 2005.
54. Diener HC, Weimar C, Katsarava Z: Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005, 18:299-304.
55. Reisman M, Christofferson RD, Jesurum J, et al.: Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005, 45:493-495.
56. Mortelmans K, Post M, Thijs V, et al.: The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005, 26:1533-1537.
57. Azarbal B, Tobis J, Suh W, et al.: Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005, 45:489-492.
58. Anzola GP, Frisoni GB, Morandi E, et al.: Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006, 37:430-434.
59. Post MC, Thijs V, Herroelen L, et al.: Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004, 62:1439-1440.
60. Sztajzel R, Genoud D, Roth S, et al.: Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002, 13:102-106.